Tempest Therapeutics Inc. (TPST)
NASDAQ · Healthcare
Tempest Therapeutics Inc. Income Statement 2013–2017
| Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 295,000 | 653,000 | 277,000 | 0 | 0 |
| Gross Profit | -495,000 | -4.7M | -2.0M | 0 | 0 |
| Profitability | |||||
| Operating Income | -84.3M | -81.0M | -72.0M | -47.9M | -29.1M |
| EBITDA | -82.7M | -78.8M | -70.7M | -47.5M | -28.9M |
| Net Income | -84.6M | -82.3M | -73.2M | -49.5M | -29.0M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 0M | 36M | 27M | 24M | 18M |
Tempest Therapeutics Inc. Income Statement — FAQ
Tempest Therapeutics Inc. (TPST) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TPST's income statement history?
The chart and table above show Tempest Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.